Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma

This article has an addendum: This observational study was summarized from clinical data, therefore the patients’ informed consents were waived. This study was approved by the Ethics Committee.

Original article: Oncotarget. 2019; 10:4069–4078. 4069-4078. https://doi.org/10.18632/oncotarget.23861